Sagittarius Life Science Corp (TPEX:3205)

Sagittarius Life Science Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	3,533	3,465	1,040	1,699	1,325	895
Market Cap Growth	224.01%	233.23%	-38.79%	28.26%	48.00%	-19.59%
Enterprise Value	3,384	2,653	890	1,480	1,137	612
Last Close Price	52.30	51.30	31.95	52.20	40.70	27.50
PS Ratio	10.21	10.01	2.22	3.86	2.50	1.52
PB Ratio	3.38	3.32	2.48	3.22	2.91	1.68
P/TBV Ratio	3.39	3.32	2.55	3.30	3.00	1.73
EV/Sales Ratio	9.78	7.67	1.90	3.36	2.15	1.04
Debt / Equity Ratio	0	0	0.03	0.03	0.03	0.05
Net Debt / Equity Ratio	-0.14	-0.14	-0.36	-0.38	-0.57	-0.62
Net Debt / EBITDA Ratio	3.14	3.14	2.67	3.50	3.45	4.06
Net Debt / FCF Ratio	4.15	4.15	3.14	2.83	4.79	8.85
Asset Turnover	0.44	0.44	0.79	0.71	0.84	0.83
Inventory Turnover	14.41	14.41	12.35	12.41	15.80	15.85
Quick Ratio	6.29	6.29	2.31	2.09	2.72	3.24
Current Ratio	31.84	31.84	2.73	2.62	3.22	3.56
Return on Equity (ROE)	-6.81%	-6.81%	-10.50%	-11.57%	-15.50%	-15.62%
Return on Assets (ROA)	-4.59%	-4.59%	-6.50%	-6.47%	-8.19%	-7.94%
Return on Invested Capital (ROIC)	-10.32%	-10.06%	-20.71%	-24.67%	-41.34%	-41.62%
Return on Capital Employed (ROCE)	-5.60%	-5.60%	-14.40%	-12.00%	-17.80%	-16.40%
Earnings Yield	-1.40%	-1.43%	-4.67%	-3.24%	-5.60%	-9.66%
FCF Yield	-1.03%	-1.05%	-4.59%	-4.20%	-4.08%	-4.18%
Buyback Yield / Dilution	-65.53%	-65.53%	-	-	-	0.22%
Total Shareholder Return	-65.53%	-65.53%	-	-	-	0.22%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.